Selected publications:
R Lucchi, J Bentanachs, B Oller-Salvia. The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control. ACS Central Science. 2021. DOI: 10.1021/acscentsci.0c01448
B Oller-Salvia, G Kym, J W Chin. Rapid and efficient generation of stable antibody-drug conjugates via an encoded cyclopropene and an inverse electron demand Diels-Alder reaction. Angewandte Chemie International Edition. 2018, 57, 2831-2834.
B Oller-Salvia, J W Chin. Efficient Phage Display with Multiple Distinct Non-Canonical Amino Acids Using Orthogonal Ribosome-Mediated Genetic Code Expansion. Angewandte Chemie International Edition. 2019, 58, 10844-10848.
_ANIE__MiniA.png)
B Oller-Salvia, M Sánchez-Navarro, E Giralt, M Teixidó. BBB-shuttle peptides: an emerging paradigm for brain delivery. Chemical Society Reviews. 2016, 45, 4690-4707.
B Oller-Salvia, M Sánchez-Navarro, S Ciudad, M Guiu, P Arranz-Gibert, C Garcia, RR Gomis, R Cecchelli, J Garcia, E Giralt, M Teixidó. MiniAp-4: a venom-inspired peptidomimetic for brain delivery. Angewandte Chemie International Edition. 2016, 55, 572-575.
_.png)
R Prades, B Oller-Salvia, MS Schwarzmaier, J Selva, M Moros, M Balbi, V Grazú, JM de la Fuente, G Egea, N Plesnila, M Teixidó, E Giralt. Jumping hurdles: revisiting the retro-enantio approach to obtain a peptide able to overcome the blood-brain barrier. Angewandte Chemie International Edition. 2015, 54, 3967-3972.
Laboratory of Protein Therapeutics
- Challenging Brain Diseases -
